The Klinique Medical Clinic PCL (BKK:KLINIQ)
Thailand · Delayed Price · Currency is THB 28.50
-0.50 (-1.72%)
Aug 11, 2026, 10:34 AM ICT
BKK:KLINIQ Financials Overview
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,829 | 3,556 | 2,983 | 2,285 | 1,639 | 949.93 |
Revenue Growth | 23.14% | 19.22% | 30.55% | 39.41% | 72.54% | -5.06% |
Gross Profit Gross Profit Growth | 1,943 | 1,796 | 1,543 | 1,235 | 922.97 | 558.77 |
Operating Income Operating Income Growth | 527.35 | 477.21 | 398.58 | 345.16 | 255.75 | 153.24 |
Net Income Net Income Growth | 400.03 | 363.7 | 322.19 | 288.62 | 205.49 | 129.26 |
Earnings Per Share EPS Growth | 1.82 | 1.65 | 1.46 | 1.31 | 1.21 | 0.81 |
EPS Growth | 20.59% | 12.88% | 11.63% | 8.34% | 49.89% | -10.67% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Aesthetic Business Aesthetic Business Growth | 2,998 |
Surgery Surgery Growth | 559.23 |
Related Party Transactions Related Party Transactions Growth | -0.86 |
Total Total Growth | 3,556 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 927.26 | 717.31 | 778.54 | 1,168 | 1,464 | 75.91 |
Total Debt Total Debt Growth | 654.84 | 677.45 | 658.04 | 461.46 | 305.1 | 206.99 |
Net Cash (Debt) Net Cash Growth | 272.43 | 39.85 | 120.5 | 707.02 | 1,159 | -131.08 |
Net Cash Growth | -8.41% | -66.92% | -82.96% | -39.02% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.24 | 0.18 | 0.55 | 3.21 | 6.83 | -0.82 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 740.15 | 660.77 | 551.98 | 385.92 | 407.96 | 238.56 |
Capital Expenditures CapEx Growth | -299.25 | -300.15 | -571.67 | -366.52 | -225.79 | -72.92 |
Free Cash Flow Free Cash Flow Growth | 440.9 | 360.62 | -19.7 | 19.39 | 182.17 | 165.64 |
Free Cash Flow Growth | 122.77% | - | - | -89.35% | 9.97% | 65.76% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 50.76% | 50.51% | 51.71% | 54.05% | 56.31% | 58.82% |
Operating Margin | 13.77% | 13.42% | 13.36% | 15.10% | 15.60% | 16.13% |
Pretax Margin | 13.31% | 12.96% | 13.10% | 15.33% | 15.02% | 15.68% |
Profit Margin | 10.45% | 10.23% | 10.80% | 12.63% | 12.54% | 13.61% |
FCF Margin | 11.52% | 10.14% | -0.66% | 0.85% | 11.11% | 17.44% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.450 | 1.450 | 1.400 | 1.300 | 0.500 | 0.356 |
Dividend Per Share Growth | 3.57% | 3.57% | 7.69% | 160.00% | 40.33% | 18.77% |
Dividend Yield | 5.09% | 6.97% | 4.66% | 3.48% | 1.49% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.95 | 12.95 | 22.19 | 32.02 | 41.49 | - |
Forward PE | 14.25 | 12.37 | 19.94 | 26.75 | - | - |
P/FCF Ratio | 14.47 | 13.06 | - | 476.45 | 46.80 | - |
PS Ratio | 1.67 | 1.32 | 2.40 | 4.04 | 5.20 | - |